Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 111

1.

Vasopressin Increases Urinary Acidification via V1a Receptors in Collecting Duct Intercalated Cells.

Giesecke T, Himmerkus N, Leipziger J, Bleich M, Koshimizu TA, Fähling M, Smorodchenko A, Shpak J, Knappe C, Isermann J, Ayasse N, Kawahara K, Schmoranzer J, Gimber N, Paliege A, Bachmann S, Mutig K.

J Am Soc Nephrol. 2019 Jun;30(6):946-961. doi: 10.1681/ASN.2018080816. Epub 2019 May 16.

PMID:
31097611
2.

Dynamic Modulation of Mouse Locus Coeruleus Neurons by Vasopressin 1a and 1b Receptors.

Campos-Lira E, Kelly L, Seifi M, Jackson T, Giesecke T, Mutig K, Koshimizu TA, Hernandez VS, Zhang L, Swinny JD.

Front Neurosci. 2018 Dec 10;12:919. doi: 10.3389/fnins.2018.00919. eCollection 2018.

3.

Complex formation between the vasopressin 1b receptor, β-arrestin-2, and the μ-opioid receptor underlies morphine tolerance.

Koshimizu TA, Honda K, Nagaoka-Uozumi S, Ichimura A, Kimura I, Nakaya M, Sakai N, Shibata K, Ushijima K, Fujimura A, Hirasawa A, Kurose H, Tsujimoto G, Tanoue A, Takano Y.

Nat Neurosci. 2018 Jun;21(6):820-833. doi: 10.1038/s41593-018-0144-y. Epub 2018 Apr 30.

PMID:
29713080
4.

Topical lidocaine inhibits spasm during colonoscopy: a double-blind, randomized controlled trial (with video).

Nemoto D, Utano K, Isohata N, Endo S, Kumamoto K, Koshimizu TA, Lefor A, Togashi K.

Endosc Int Open. 2017 Jun;5(6):E402-E407. doi: 10.1055/s-0043-105489. Epub 2017 May 30.

5.

Axitinib-induced Pneumatosis Intestinalis and Acute Acalculous Cholecystitis in a Patient With Renal Cell Carcinoma.

Kameda T, Nakano K, Yamazaki M, Koshimizu T, Morita T.

Urology. 2017 Mar;101:e7-e8. doi: 10.1016/j.urology.2016.12.035. Epub 2016 Dec 27.

PMID:
28039049
6.

Combined sodium ion sensitivity in agonist binding and internalization of vasopressin V1b receptors.

Koshimizu TA, Kashiwazaki A, Taniguchi J.

Sci Rep. 2016 May 3;6:25327. doi: 10.1038/srep25327.

7.

Lipopolysaccharide-induced inflammation or unilateral ureteral obstruction yielded multiple types of glycosylated Lipocalin 2.

Fujiwara Y, Tsuchiya H, Sakai N, Shibata K, Fujimura A, Koshimizu TA.

J Inflamm (Lond). 2016 Mar 5;13:7. doi: 10.1186/s12950-016-0116-5. eCollection 2016.

8.

Prostaglandin D2 elicits the reversible neurite retraction in hypothalamic cell line.

Tsuchiya H, Hohjoh H, Fujiwara Y, Sugimoto Y, Koshimizu TA.

Biochem Biophys Res Commun. 2016 Feb 19;470(4):804-10. doi: 10.1016/j.bbrc.2016.01.091. Epub 2016 Jan 26.

PMID:
26820529
9.

Identification of protein arginine N-methyltransferase 5 (PRMT5) as a novel interacting protein with the tumor suppressor protein RASSF1A.

Sakai N, Saito Y, Fujiwara Y, Shiraki T, Imanishi Y, Koshimizu TA, Shibata K.

Biochem Biophys Res Commun. 2015 Nov 27;467(4):778-84. doi: 10.1016/j.bbrc.2015.10.065. Epub 2015 Oct 20.

PMID:
26482848
10.

Subcellular localization and internalization of the vasopressin V1B receptor.

Kashiwazaki A, Fujiwara Y, Tsuchiya H, Sakai N, Shibata K, Koshimizu TA.

Eur J Pharmacol. 2015 Oct 15;765:291-9. doi: 10.1016/j.ejphar.2015.08.043. Epub 2015 Aug 28.

PMID:
26318147
11.

Pharmacological lineage analysis revealed the binding affinity of broad-spectrum substance P antagonists to receptors for gonadotropin-releasing peptide.

Arai K, Kashiwazaki A, Fujiwara Y, Tsuchiya H, Sakai N, Shibata K, Koshimizu TA.

Eur J Pharmacol. 2015 Feb 15;749:98-106. doi: 10.1016/j.ejphar.2015.01.001. Epub 2015 Jan 12.

PMID:
25592317
12.

[Chapter 3. Transitions in clinical trials and appropriate use of drugs in Japan (1980-2010)].

Koshimizu T.

Yakushigaku Zasshi. 2014;49(1):50-63. Japanese.

PMID:
25272637
13.

Dysregulated gene expression in the primary osteoblasts and osteocytes isolated from hypophosphatemic Hyp mice.

Miyagawa K, Yamazaki M, Kawai M, Nishino J, Koshimizu T, Ohata Y, Tachikawa K, Mikuni-Takagaki Y, Kogo M, Ozono K, Michigami T.

PLoS One. 2014 Apr 7;9(4):e93840. doi: 10.1371/journal.pone.0093840. eCollection 2014.

14.

Voluntary locomotion linked with cerebral activation is mediated by vasopressin V1a receptors in free-moving mice.

Masuki S, Sumiyoshi E, Koshimizu TA, Qian J, Higuchi K, Tsujimoto G, Nose H.

J Physiol. 2013 Jul 15;591(14):3651-65. doi: 10.1113/jphysiol.2013.251876. Epub 2013 May 13.

15.

α-Lipoic acid protects against arsenic trioxide-induced acute QT prolongation in anesthetized guinea pigs.

Kumazaki M, Ando H, Kakei M, Ushijima K, Taniguchi Y, Yoshida M, Yamato S, Washino S, Koshimizu TA, Fujimura A.

Eur J Pharmacol. 2013 Apr 5;705(1-3):1-10. doi: 10.1016/j.ejphar.2013.02.027. Epub 2013 Mar 5.

PMID:
23474023
16.

Serum amyloid A upsurge precedes standard biomarkers of hepatotoxicity in ritodrine-injected mice.

Tsuchiya H, Sato J, Tsuda H, Fujiwara Y, Yamada T, Fujimura A, Koshimizu TA.

Toxicology. 2013 Mar 8;305:79-88. doi: 10.1016/j.tox.2013.01.012. Epub 2013 Jan 28.

PMID:
23370008
17.

Metastasis-associated protein, S100A4 mediates cardiac fibrosis potentially through the modulation of p53 in cardiac fibroblasts.

Tamaki Y, Iwanaga Y, Niizuma S, Kawashima T, Kato T, Inuzuka Y, Horie T, Morooka H, Takase T, Akahashi Y, Kobuke K, Ono K, Shioi T, Sheikh SP, Ambartsumian N, Lukanidin E, Koshimizu TA, Miyazaki S, Kimura T.

J Mol Cell Cardiol. 2013 Apr;57:72-81. doi: 10.1016/j.yjmcc.2013.01.007. Epub 2013 Jan 23.

PMID:
23352991
18.

Vasopressin V1a and V1b receptors: from molecules to physiological systems.

Koshimizu TA, Nakamura K, Egashira N, Hiroyama M, Nonoguchi H, Tanoue A.

Physiol Rev. 2012 Oct;92(4):1813-64. doi: 10.1152/physrev.00035.2011. Review.

19.

Basal metabolic rate and body composition of elite Japanese male athletes.

Koshimizu T, Matsushima Y, Yokota Y, Yanagisawa K, Nagai S, Okamura K, Komatsu Y, Kawahara T.

J Med Invest. 2012;59(3-4):253-60.

20.

Vinculin functions as regulator of chondrogenesis.

Koshimizu T, Kawai M, Kondou H, Tachikawa K, Sakai N, Ozono K, Michigami T.

J Biol Chem. 2012 May 4;287(19):15760-75. doi: 10.1074/jbc.M111.308072. Epub 2012 Mar 13.

21.

Dysfunction of lipid sensor GPR120 leads to obesity in both mouse and human.

Ichimura A, Hirasawa A, Poulain-Godefroy O, Bonnefond A, Hara T, Yengo L, Kimura I, Leloire A, Liu N, Iida K, Choquet H, Besnard P, Lecoeur C, Vivequin S, Ayukawa K, Takeuchi M, Ozawa K, Tauber M, Maffeis C, Morandi A, Buzzetti R, Elliott P, Pouta A, Jarvelin MR, Körner A, Kiess W, Pigeyre M, Caiazzo R, Van Hul W, Van Gaal L, Horber F, Balkau B, Lévy-Marchal C, Rouskas K, Kouvatsi A, Hebebrand J, Hinney A, Scherag A, Pattou F, Meyre D, Koshimizu TA, Wolowczuk I, Tsujimoto G, Froguel P.

Nature. 2012 Feb 19;483(7389):350-4. doi: 10.1038/nature10798.

PMID:
22343897
22.

Chronic ritodrine treatment induces refractoriness of glucose-lowering β2 adrenoceptor signal in female mice.

Tsuchiya H, Ushijima K, Fujiwara Y, Fujimura A, Koshimizu TA.

Regul Toxicol Pharmacol. 2012 Apr;62(3):561-7. doi: 10.1016/j.yrtph.2011.11.011. Epub 2011 Dec 1.

PMID:
22154823
23.

The roles of V1a vasopressin receptors in blood pressure homeostasis: a review of studies on V1a receptor knockout mice.

Fujiwara Y, Tanoue A, Tsujimoto G, Koshimizu TA.

Clin Exp Nephrol. 2012 Feb;16(1):30-4. doi: 10.1007/s10157-011-0497-y. Epub 2011 Nov 1. Review.

PMID:
22038263
24.

Proximal tubules and podocytes are toxicity targets of bucillamine in a mouse model of drug-induced kidney injury.

Fujiwara Y, Tsuchiya H, Sakai N, Shibata K, Fujimura A, Koshimizu TA.

Eur J Pharmacol. 2011 Nov 16;670(1):208-15. doi: 10.1016/j.ejphar.2011.08.051. Epub 2011 Sep 16.

PMID:
21933671
25.

Protective effect of α-lipoic acid against arsenic trioxide-induced acute cardiac toxicity in rats.

Kumazaki M, Ando H, Sasaki A, Koshimizu TA, Ushijima K, Hosohata K, Oshima Y, Fujimura A.

J Pharmacol Sci. 2011;115(2):244-8. Epub 2011 Jan 26.

26.
27.

Signaling of extracellular inorganic phosphate up-regulates cyclin D1 expression in proliferating chondrocytes via the Na+/Pi cotransporter Pit-1 and Raf/MEK/ERK pathway.

Kimata M, Michigami T, Tachikawa K, Okada T, Koshimizu T, Yamazaki M, Kogo M, Ozono K.

Bone. 2010 Nov;47(5):938-47. doi: 10.1016/j.bone.2010.08.006. Epub 2010 Aug 13.

PMID:
20709201
28.

Oxytocin stimulates expression of a noncoding RNA tumor marker in a human neuroblastoma cell line.

Koshimizu TA, Fujiwara Y, Sakai N, Shibata K, Tsuchiya H.

Life Sci. 2010 Mar 13;86(11-12):455-60. doi: 10.1016/j.lfs.2010.02.001. Epub 2010 Feb 10.

PMID:
20149803
29.

Inhibition of heat shock protein 90 attenuates adenylate cyclase sensitization after chronic morphine treatment.

Koshimizu TA, Tsuchiya H, Tsuda H, Fujiwara Y, Shibata K, Hirasawa A, Tsujimoto G, Fujimura A.

Biochem Biophys Res Commun. 2010 Feb 19;392(4):603-7. doi: 10.1016/j.bbrc.2010.01.089. Epub 2010 Jan 25.

PMID:
20100459
30.

Cranberry juice suppressed the diclofenac metabolism by human liver microsomes, but not in healthy human subjects.

Ushijima K, Tsuruoka S, Tsuda H, Hasegawa G, Obi Y, Kaneda T, Takahashi M, Maekawa T, Sasaki T, Koshimizu TA, Fujimura A.

Br J Clin Pharmacol. 2009 Aug;68(2):194-200. doi: 10.1111/j.1365-2125.2009.03436.x.

31.

Vasopressin regulation of blood pressure and volume: findings from V1a receptor-deficient mice.

Aoyagi T, Koshimizu TA, Tanoue A.

Kidney Int. 2009 Nov;76(10):1035-9. doi: 10.1038/ki.2009.319. Epub 2009 Aug 19. Review.

32.

Prostate growth inhibition by subtype-selective alpha(1)-adrenoceptor antagonist naftopidil in benign prostatic hyperplasia.

Kojima Y, Sasaki S, Oda N, Koshimizu TA, Hayashi Y, Kiniwa M, Tsujimoto G, Kohri K.

Prostate. 2009 Oct 1;69(14):1521-8. doi: 10.1002/pros.21003.

PMID:
19544328
33.

Novel selective ligands for free fatty acid receptors GPR120 and GPR40.

Hara T, Hirasawa A, Sun Q, Sadakane K, Itsubo C, Iga T, Adachi T, Koshimizu TA, Hashimoto T, Asakawa Y, Tsujimoto G.

Naunyn Schmiedebergs Arch Pharmacol. 2009 Sep;380(3):247-55. doi: 10.1007/s00210-009-0425-9. Epub 2009 May 27.

PMID:
19471906
34.

Signaling by purinergic receptors and channels in the pituitary gland.

Stojilkovic SS, He ML, Koshimizu TA, Balik A, Zemkova H.

Mol Cell Endocrinol. 2010 Jan 27;314(2):184-91. doi: 10.1016/j.mce.2009.05.008. Epub 2009 May 23. Review.

35.

New topics in vasopressin receptors and approach to novel drugs: vasopressin and pain perception.

Koshimizu TA, Tsujimoto G.

J Pharmacol Sci. 2009 Jan;109(1):33-7. Review.

36.

Flow cytometry-based binding assay for GPR40 (FFAR1; free fatty acid receptor 1).

Hara T, Hirasawa A, Sun Q, Koshimizu TA, Itsubo C, Sadakane K, Awaji T, Tsujimoto G.

Mol Pharmacol. 2009 Jan;75(1):85-91. doi: 10.1124/mol.108.052225. Epub 2008 Oct 16.

PMID:
18927207
37.

Cloning and characterization of the rat free fatty acid receptor GPR120: in vivo effect of the natural ligand on GLP-1 secretion and proliferation of pancreatic beta cells.

Tanaka T, Yano T, Adachi T, Koshimizu TA, Hirasawa A, Tsujimoto G.

Naunyn Schmiedebergs Arch Pharmacol. 2008 Jun;377(4-6):515-22. doi: 10.1007/s00210-007-0250-y. Epub 2008 Mar 5.

PMID:
18320172
38.

Neural discriminant analysis.

Tsujitani M, Koshimizu T.

IEEE Trans Neural Netw. 2000;11(6):1394-401. doi: 10.1109/72.883460.

PMID:
18249863
39.

Production and characterization of a monoclonal antibody against GPR40 (FFAR1; free fatty acid receptor 1).

Hirasawa A, Itsubo C, Sadakane K, Hara T, Shinagawa S, Koga H, Nose H, Koshimizu TA, Tsujimoto G.

Biochem Biophys Res Commun. 2008 Jan 4;365(1):22-8. Epub 2007 Oct 31.

PMID:
17980148
40.

Free fatty acids induce cholecystokinin secretion through GPR120.

Tanaka T, Katsuma S, Adachi T, Koshimizu TA, Hirasawa A, Tsujimoto G.

Naunyn Schmiedebergs Arch Pharmacol. 2008 Jun;377(4-6):523-7. Epub 2007 Oct 31.

PMID:
17972064
41.

Involvement of nuclear factor I transcription/replication factor in the early stage of chondrocytic differentiation.

Uchihashi T, Kimata M, Tachikawa K, Koshimizu T, Okada T, Ihara-Watanabe M, Sakai N, Kogo M, Ozono K, Michigami T.

Bone. 2007 Dec;41(6):1025-35. Epub 2007 Aug 30.

PMID:
17904922
42.

Effects of a fixed dietary intake on changes in red blood cell delta-aminolevulinate dehydratase activity and hemolysis.

Ishizaki S, Koshimizu T, Yanagisawa K, Akiyama Y, Mekada Y, Shiozawa N, Takahashi N, Yamakawa J, Kawano Y.

Int J Sport Nutr Exerc Metab. 2006 Dec;16(6):597-610.

PMID:
17342881
43.

Objective evaluation of generic-specific drug information.

Iijima H, Koshimizu T, Shiragami M.

Yakugaku Zasshi. 2007 Mar;127(3):541-5. Japanese.

44.

Glucocorticoid-induced granzyme A expression can be used as a marker of glucocorticoid sensitivity for acute lymphoblastic leukemia therapy.

Myoumoto A, Nakatani K, Koshimizu TA, Matsubara H, Adachi S, Tsujimoto G.

J Hum Genet. 2007;52(4):328-33. Epub 2007 Feb 20.

PMID:
17310274
45.

Clinical implications from studies of alpha1 adrenergic receptor knockout mice.

Koshimizu TA, Tanoue A, Tsujimoto G.

Biochem Pharmacol. 2007 Apr 15;73(8):1107-12. Epub 2006 Nov 7. Review.

PMID:
17141736
46.

Functional role of spliced cytoplasmic tails in P2X2-receptor-mediated cellular signaling.

Koshimizu TA, Tsujimoto G.

J Pharmacol Sci. 2006 Aug;101(4):261-6. Epub 2006 Aug 5. Review.

47.

V1a vasopressin receptors maintain normal blood pressure by regulating circulating blood volume and baroreflex sensitivity.

Koshimizu TA, Nasa Y, Tanoue A, Oikawa R, Kawahara Y, Kiyono Y, Adachi T, Tanaka T, Kuwaki T, Mori T, Takeo S, Okamura H, Tsujimoto G.

Proc Natl Acad Sci U S A. 2006 May 16;103(20):7807-12. Epub 2006 May 8.

48.

Carboxyl-terminal splicing enhances physical interactions between the cytoplasmic tails of purinergic P2X receptors.

Koshimizu TA, Kretschmannova K, He ML, Ueno S, Tanoue A, Yanagihara N, Stojilkovic SS, Tsujimoto G.

Mol Pharmacol. 2006 May;69(5):1588-98. Epub 2006 Feb 8.

PMID:
16467187
49.

Free fatty acids administered into the colon promote the secretion of glucagon-like peptide-1 and insulin.

Adachi T, Tanaka T, Takemoto K, Koshimizu TA, Hirasawa A, Tsujimoto G.

Biochem Biophys Res Commun. 2006 Feb 3;340(1):332-7. Epub 2005 Dec 7.

PMID:
16356474
50.

Molecular dissection of purinergic P2X receptor channels.

Stojilkovic SS, Tomic M, He ML, Yan Z, Koshimizu TA, Zemkova H.

Ann N Y Acad Sci. 2005 Jun;1048:116-30.

PMID:
16154926

Supplemental Content

Loading ...
Support Center